- AI in Lab Coat
- Posts
- AI Connects Drug to Parkinson’s Protection
AI Connects Drug to Parkinson’s Protection
plus: RFK Says AI Can Fix Rural Healthcare

Happy Friday! It’s January 31st.
Chinese AI startup DeepSeek has stunned the industry with its R1 model, rivaling OpenAI at 95% lower costs, sparking a U.S. tech stock sell-off. Its rapid rise is fueling fears that China is closing the AI gap, challenging U.S. tech dominance.
Our picks for the week:
Featured Research:AI Connects Drug to Parkinson’s Protection
Perspectives: Robert F. Kennedy Jr. Says AI Can Fix Rural Healthcare
Product Pipeline: Portable Retinal Imaging Gets FDA Nod
Policy & Ethics: FDA AI Oversight: Tension Rises
FEATURED RESEARCH
AI Links Common Drug With Potential to Lower Parkinson’s Risk

Parkinson’s disease does more than cause tremors. It affects thinking, sleep, and balance, increasing the risk of dementia and falls. Over 6.2 million people worldwide have it, and that number is expected to double by 2040.
Current treatments manage symptoms, but nothing slows the disease itself. That’s why researchers turned to AI to find new options—by looking at old drugs.
AI Connects the Dots: A research team at Cleveland Clinic used AI and deep learning to sift through massive datasets, combining genetics, protein interactions, and electronic health records (EHRs).
Their model analyzed 175 high-risk genes linked to Parkinson’s, searching for drugs that interact with them. One stood out: simvastatin, a common cholesterol-lowering medication.
Real-world evidence suggests a link: The team’s analysis found that patients taking simvastatin had a 12% lower risk of Parkinson’s-related dementia and a 9% lower risk of falls.
The drug also interacts with six key proteins involved in Parkinson’s, suggesting a possible biological mechanism.
Previous trials have raised doubts: A recent phase II clinical trial found that simvastatin failed as a disease-modifying therapy for Parkinson’s. But the trial had only 235 participants, nearly all white, and only included moderate-to-severe cases.
The AI study, in contrast, looked at a much larger, more diverse real-world dataset. That doesn’t mean simvastatin works, it means a better-designed trial is needed to find out.
What’s next? This isn’t a reason to start taking statins for Parkinson’s prevention, not yet anyway. More research and clinical trials with ethnically diverse, early- and late-stage patients are needed.
But if these findings hold up, AI may have uncovered a low-cost, widely available option to reduce Parkinson’s risk. A rare and much-needed breakthrough in a disease that has few.
For more details: Full Article
Brain Booster
Many people think Earth is closer to the Sun in summer and farther in winter. What’s the real reason for the seasons? |
Select the right answer! (See explanation below)
Opinion and Perspectives
RURAL HEALTHCARE
Robert F. Kennedy Jr. Promises AI-Driven Healthcare for Remote Communities
Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services secretary, is making rural hospitals a top priority. At his Senate confirmation hearing, Kennedy told lawmakers that AI and telemedicine will play a central role in reversing the decline of healthcare access in rural America.
AI-driven solutions could change rural care: Kennedy pointed to innovations like an AI nurse developed at Cleveland Clinic that he claims is "indistinguishable from a human" and can diagnose as accurately as a doctor. He sees AI as a tool to bring concierge-level healthcare to even the most remote parts of the U.S., including Wyoming, Montana, and Alaska.
Rural hospitals are struggling: The American Hospital Association (AHA) warns that low patient volumes make it tough for these hospitals to stay financially stable. Many are already operating on razor-thin margins and face higher risks from policy shifts, Medicare cuts, and economic downturns. Kennedy argues that AI-powered solutions could fill critical workforce gaps and stabilize these facilities.
Kennedy’s confirmation is far from certain, but his plan makes one thing clear: AI in healthcare is no longer a distant future, it’s a political priority.
For more details: Full Article
Top Funded Startups
Product Pipeline
PORTABLE RETINAL SCANNER
FDA Clears AI-Powered Handheld Retinal Camera for Early Disease Detection
AI Optics’ Sentinel Camera just received FDA 510(k) clearance, bringing AI-driven retinal imaging to the point of care. Millions miss out on screening due to specialist shortages and cost barriers.
This handheld, easy-to-use device captures high-quality, non-dilated images, helping primary care providers, optometrists, and retail clinics detect diseases like diabetic retinopathy and glaucoma earlier.
Through a partnership with NYU Langone Health, AI Optics is expanding access to retinal screening in more healthcare settings.
Future AI-based screening software will further improve detection and efficiency. With EHR integration and a focus on accessibility, the Sentinel Camera is making early retinal disease detection faster and more widely available.
For more details: Full Article
Policy and Ethics
AI REGULATION
FDA Faces Growing Debate Over How to Regulate Generative AI in Healthcare

The FDA’s approach to generative AI is creating a divide among stakeholders. AdvaMed, which represents medical device and digital health companies, believes the agency’s existing regulations, including the total product lifecycle approach, are enough to manage these technologies. Adding new rules, they argue, could slow innovation without clear benefits.
The American College of Radiology sees it differently. They’re pushing for updated premarket evaluation, stronger postmarket oversight, and clearer guidance on foundation model transparency and equity testing. Generative AI brings new challenges, and they want regulations that reflect that reality.
The FDA will need to find a balance, keeping innovation moving while ensuring patient safety stays the top priority.
For more details: Full Article
Byte-Sized Break
📢 Three Things AI Did This Week
Alibaba has released its Qwen 2.5 AI model, claiming it outperforms DeepSeek-V3, GPT-4o, and Llama-3.1-405B, as competition intensifies in China's AI landscape. [Link]
OpenAI and Microsoft are investigating whether China’s DeepSeek used OpenAI’s API and distillation techniques to train its AI models, potentially violating OpenAI’s terms of service. [Link]
A Minnesota court threw out an AI-generated expert declaration supporting an anti-deepfake law after discovering fake citations, highlighting the growing legal scrutiny over AI's reliability in court filings. [Link]
Have a Great Weekend!
![]() | ❤️ Help us create something you'll love—tell us what matters! 💬 We read all of your replies, comments, and questions. 👉 See you all next week! - Bauris |
Trivia Answer: C) Earth's axial tilt changes how sunlight hits each hemisphere
Earth is tilted at 23.4 degrees, meaning different parts of the planet get more direct sunlight at different times of the year. That’s why it’s winter in the Northern Hemisphere when it’s summer in the Southern Hemisphere—nothing to do with distance from the Sun!
How did we do this week? |
Reply